Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS

Click for more information

0.00%

0.5¢ unilife corporation

Unilife Mention in Biodel's 4th Qtr Results, page-3

First 3 Last

Share
Profile

Follow
Karljasper

479 Posts.

19/12/14

05:12

Post #: 14484711
Share

Originally posted by rustyone ↑

View attachment 34666
http://www.biodel.com/content/pipeline/glucagon.htm

We are developing room temperature stable glucagon presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia. In June 2013, we announced plans to develop a novel glucagon rescue product to treat severe hypoglycemia using a proprietary device from Unilife Corporation. The device, which is being customized for use in emergency situations by patient caregivers with no medical training, is a dual-chamber design that reconstitutes lyophilized glucagon with a liquid diluent immediately prior to injection, and it features automatic needle retraction on full dose delivery. We expect to submit an Investigational New Drug application to the FDA for our dual-chamber glucagon rescue product during the next nine months and anticipate conducting a pivotal clinical trial in the second half of 2014. We are also conducting preclinical testing to develop liquid formulations of glucagon for hypoglycemic rescue and other indications.

Expand

Rusty - Great find! I love how this functions as a system. Very cool! Maybe this study will receive breakthrough designation so it doesn't take so blasted long.

UNS Price at posting: 60.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

US election outcomes: Key economic and market takeaways

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 3 Last

Add UNS (ASX) to my watchlist